a Study of EGFR & ALK Test in Lung cancer patients.
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Lung Cancer Patients
- Registration Number
- CTRI/2017/10/010086
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 500
Inclusion Criteria
Specimens with adequate tumor burden ( >50% of tumors cells) will taken for the FISH
analysis. The assessment will be done by a pathologist on the H&E.
Exclusion Criteria
No Exclusion criteria as the study is to be done only on the Tumor tissue blocks.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The Specific aims of the proposed study are to conduct a large-scale study among Lung Cancer patients in <br/ ><br>India to <br/ ><br>a) Estimate the prevalence of EGFR and EML4-ALK fusion in Indian NSCLC (adenocarcinoma) patient population; <br/ ><br>b) Evaluate the association of EGFR and EML4-ALK fusion with clinical and pathologic parameters of <br/ ><br>NSCLC (adenocarcinoma) and patient characteristics; <br/ ><br>Timepoint: End of the study
- Secondary Outcome Measures
Name Time Method ot applicableTimepoint: Not Applicable